BriaCell Therapeutics Corp. (BCTXL) Warrants
Each BCTXL warrant gives the holder the right to buy 1 share of BriaCell Therapeutics Corp. at $6.93 per share, until January 15, 2031. The stock last closed at $3.16, below the strike, so the warrant is out of the money. BriaCell Therapeutics Corp. has a market value of about $27.59M. There are 5.37M listed warrants; exercising all of them would add 61.5% to the 8.73M shares outstanding.
BriaCell Therapeutics Corp. reports its business to the SEC as “Pharmaceutical Preparations”, with its head office in West Vancouver, British Columbia, Canada; it is incorporated in British Columbia, Canada. Its latest SEC filing was on October 28, 2026: annual report, form 10-K. The warrant closed at $0.8200 on November 19, 2026, down 12% from $0.9300 on January 14, 2026. Over the last 22 trading days it traded on 22, about $15,000 a day. BCTX would have to rise 119% to reach the strike, and 145% (to $7.75) to cover the warrant's price as well.
Key terms
- Strike per share
- $6.93
- Shares per warrant
- 1
- Cash to exercise one warrant
- $6.93
- Expiry
- 2031-01-15
- Redemption trigger
- none stated
- Cashless exercise
- allowed
- Break-even stock price
- $7.75
Checked against the issuer's SEC filing of 2026. The terms were first set out in its S-1/A of 2025-07-10.
Exercise calculator
Each warrant buys 1 share at $6.93. Before expiry a warrant usually sells for more than its exercise value, because it still has time left. Fees and taxes are not included. Arithmetic, not investment advice.
Company and stock
- Company
- BriaCell Therapeutics Corp.
- Underlying stock
- BCTX
- Share price
- $3.16
- Market cap
- $27.59M
- Shares outstanding
- 8.73M
- 12-month range
- $2.74 – $12.64
- 12-month change
- -59%
- Value of all listed warrants
- $4.40M (15.9% of market cap)
- Industry
- Pharmaceutical Preparations
- Head office
- West Vancouver, British Columbia, Canada
- Incorporated in
- British Columbia, Canada
Market cap is the last share price times shares outstanding (as of 2026-10-28). Industry and head office are as the company reports them to the SEC. All SEC filings for this company.
Model value Pro · free for now
The answer moves with the volatility assumed.
- Last price
- $0.8200
- Low and high estimate
- $0.6543 – $1.81
- Stock volatility, measured
- 126% (three days make up most of it)
- Volatility we use
- 50% · 80% · 100%
- Volatility the price implies
- 55%
- Effect of dilution
- −2.7%
- Method
- exact Black-Scholes formula
The estimate uses a volatility below the one measured, because measured volatility overstates what the market pays for. Not investment advice.
Dilution
- Shares outstanding
- 8.73M
- Listed warrants
- 5.37M
- Dilution if all exercised
- 61.5%
Warrant count from the notes to the company's financial statements. Confidence: high.
Filings
- 10-KAnnual report
- 8-KCurrent report: investor update
- 10-QQuarterly report
- 8-KCurrent report: material agreement; unregistered sale of shares; other events
- 424B5Prospectus
- 8-KCurrent report: investor update
- 10-QQuarterly report
- 8-KCurrent report: shareholder vote results
- 25-NSEDelisting from the exchange Key
- 8-KCurrent report: other events
The company's latest SEC filings, checked every night. Insider trades and routine SEC paperwork are left out. All SEC filings for this company.
Events
Questions about BCTXL
When does the BCTXL warrant expire?
BCTXL expires on January 15, 2031.
What is the strike price of BCTXL?
$6.93 per share; each warrant converts into 1 share, so exercising one warrant costs $6.93.
Can BriaCell Therapeutics Corp. redeem the BCTXL warrants early?
The source filing we read lists no stock-price redemption trigger.
How many BCTXL warrants are outstanding?
5.37M listed warrants, equal to 61.5% dilution if all are exercised.
Related warrants
Get an email when alerts open
Follow BCTXL with the button at the top to get its alerts. Alerts are coming soon; leave your email and we will tell you when they open.

